Ai Centrum Medyczne

Poznan 61-113

0 studies enrolling now · 9 studies all time

What they study most

Active Psoriatic Arthritis, Chronic Plaque Psoriasis, Crohn's Disease, Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, Sjogren's Syndrome, Sjogrens Syndrome, Systemic Lupus Erythematosus

Studies at this site

• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
• Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis — Completed
• A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus — Completed
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) — Completed
• A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) — Completed
• Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome — Completed
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis — Completed
• Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease — Stopped early
• Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis — Completed